SCHEMBL6037155

SCHEMBL6037155

O=S(=O)(O)c1cc(/N=N/c2ccc(O)cc2)ccc1/C=C/c1ccc(/N=N/c2ccc(O)cc2)cc1S(=O)(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD1 O60671 1/20 0.63
▸ P2RY6 Q15077 1/20 0.63
▸ SENP2 Q9HC62 5/20 0.56
▸ SENP1 Q9P0U3 5/20 0.56
▸ SENP3 Q9H4L4 4/20 0.56
▸ SUMO2 P61956 3/20 0.56
▸ SUMO1 P63165 3/20 0.56
▸ SENP7 Q9BQF6 3/20 0.56
▸ CA12 O43570 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ GLO1 Q04760 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ RAD51 Q06609 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ USP2 O75604 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ LTA P01374 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ MAPT P10636 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29384039 1.00 RAD1 (0.63) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL6037159 1.00 RAD1 (0.63) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL19882736 1.00 RAD1 (0.63) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL17518462 1.00 RAD1 (0.63) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL19154120 1.00 RAD1 (0.63) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL2421728 0.98 RAD1 (0.61) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL29495135 0.98 RAD1 (0.61) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL2421720 0.98 RAD1 (0.61) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL29351268 0.98 RAD1 (0.61) RAD1P2RY6SENP2SENP1SENP3
SCHEMBL26725620 0.94 RAD1 (0.57) RAD1P2RY6SENP2SENP1SENP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 — — US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 — — US disclosed
US-20060070135-A1 Compositions and methods for inhibiting the enzymatic activity of PTP-1B TREMBLAY MICHEL 2006-03-30 — — US disclosed
US-4058607-A DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES AIRWICK INDUSTRIES, INC. (US) 1977-11-15 — — US disclosed
US-3966900-A INSECTICIDES AIRWICK INDUSTRIES, INC. (US) 1976-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 RAD1 2618/4885P2RY6 268/4885SENP2 4173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback